Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors

2002 ◽  
Vol 71 (5) ◽  
pp. 334-348 ◽  
Author(s):  
D Mould
Keyword(s):  
Adverse Event ◽  
Solid Tumors ◽  
Population Pharmacokinetic ◽  
Event Analysis

Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors

2009 ◽  
Vol 49 (10) ◽  
pp. 1142-1156 ◽  
Author(s):  
Peiming Ma ◽  
Bing-Bing Yang ◽  
Yow-Ming Wang ◽  
Mark Peterson ◽  
Adimoolam Narayanan ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Population Pharmacokinetic Analysis ◽  
Pharmacokinetic Analysis ◽  
Population Pharmacokinetic ◽  
Advanced Solid Tumors

scholarly journals Evaluation of the adverse event profile and pharmacodynamics of toceranib phosphate administered to dogs with solid tumors at doses below the maximum tolerated dose

2013 ◽  
Vol 9 (1) ◽  
pp. 190 ◽  
Author(s):  
Luis Bernabe ◽  
Roberta Portela ◽  
Sandra Nguyen ◽  
William C Kisseberth ◽  
Michael Pennell ◽  
...  
Keyword(s):  
Adverse Event ◽  
Solid Tumors ◽  
Maximum Tolerated Dose ◽  
Adverse Event Profile

Pertussis outbreak in Polish shooters with adverse event analysis

2017 ◽  
Vol 3 ◽  
pp. 243-248
Author(s):  
Monika Skrzypiec-Spring ◽  
Jarosław Krzywański ◽  
Monika Karlikowska-Skwarnik ◽  
Andrzej Pokrywka ◽  
Hubert Krysztofiak ◽  
...  
Keyword(s):  
Adverse Event ◽  
Event Analysis
Sign in / Sign up

Export Citation Format

Share Document